Halma plc (HLMA.L) Bundle
From its origins in 1894 to a modern group operating in over 20 countries, Halma plc has built a distinct identity focused on life-saving technologies across safety, environmental and healthcare sectors, and with a portfolio of 45 companies and reported revenues of £2.034 billion for the fiscal year ending March 2024 the business translates purpose into measurable scale; guided by the mission to "grow a safer, cleaner, healthier future for everyone, every day," Halma couples a vision to lead in safety, health and compliance with core values - integrity, innovation, collaboration, responsibility and excellence - while pursuing a Sustainable Growth Model and targeted acquisitions that reinforce its commitment to protect life-critical resources and advance healthcare and environmental outcomes.
Halma plc (HLMA.L) - Intro
Halma plc is a UK-based global group specialising in life‑saving technologies across safety, environmental and healthcare sectors. Established in 1894, Halma has evolved from a tea‑estate company into a diversified technology leader that addresses global challenges through product innovation and targeted acquisitions. The group operates across more than 20 countries and, through a decentralised model, manages a portfolio of 45 specialist companies focused on improving safety, health and environmental sustainability.- Founded: 1894
- Operations: 20+ countries
- Portfolio: 45 companies
- Fiscal year (ended Mar 2024) revenue: £2.034 billion
- Business model: organic innovation plus strategic acquisitions aligned to purpose
| Metric | Value |
|---|---|
| Revenue (FY Mar 2024) | £2.034 billion |
| Number of portfolio companies | 45 |
| Geographic footprint | 20+ countries |
| Founded | 1894 |
| Primary sectors | Safety, Environmental, Healthcare technologies |
- To deliver life‑saving technology that protects people and the environment.
- To grow value for stakeholders by scaling specialist businesses that meet critical safety and health needs.
- Be the global leader in technologies that prevent hazards, protect health and preserve the environment.
- Create long‑term, measurable impact by deploying specialist expertise across diverse markets and regions.
- Purpose‑driven: every acquisition and product line is evaluated against life‑saving or environmental benefit.
- Decentralisation: empowered, specialist management teams run businesses with operational autonomy.
- Long‑term stewardship: capital allocation prioritises sustainable growth and technologies with enduring impact.
- Innovation and expertise: investment in R&D and technical excellence within each portfolio company.
- Ethical governance: adherence to strong governance, compliance and responsible business practices.
- Acquisitions that complement core sectors and provide niche technical capability.
- Organic expansion via product innovation, cross‑selling and international roll‑out of proven solutions.
- Operational support: shared services and capital enable scale while preserving specialist cultures.
- Revenue growth and margin improvement across safety, environmental and healthcare segments.
- Integration of acquired businesses to preserve technical capability while achieving scale benefits.
- Trackable social and environmental impact tied to product outcomes and lifecycle benefits.
Halma plc (HLMA.L) - Overview
Halma's mission is to 'grow a safer, cleaner, healthier future for everyone, every day.' This clear, purpose-led statement drives strategy, capital allocation, and product development across the group's specialist safety, environmental and healthcare technology businesses.- Purpose-driven focus: technologies solving real-world problems in safety, environmental protection and healthcare delivery.
- Sustainability built-in: protecting life-critical resources (water, air, energy) and improving patient outcomes.
- Consistent capital reinvestment: sustained R&D and targeted acquisitions to extend mission reach.
- R&D commitment: the group reinvests a meaningful portion of revenue into product development and regulatory approvals, concentrating on life-critical and safety technologies.
- Acquisition strategy: Halma acquires specialist businesses that complement its mission, expanding both technology capability and geographic reach.
- Global footprint: a portfolio of businesses operating across many markets to deliver mission outcomes at scale.
| Metric | Representative figure / note |
|---|---|
| Group companies | Over 70 specialist businesses across safety, environment and health |
| Employees | Approximately 7,500 people worldwide |
| Geographic reach | Operations and sales in 100+ countries |
| R&D intensity | Roughly mid-single-digit percent of revenue invested in R&D annually |
| Acquisition activity | Multiple strategic acquisitions per year on average; targeted to add mission-aligned technologies and capabilities |
- Investment priority: projects and product lines with clear safety, environmental or healthcare benefit receive preferential funding.
- Acquisition filter: target businesses must demonstrably enhance the group's ability to grow a safer, cleaner, healthier future.
- Long-term view: emphasis on steady organic growth supported by bolt-on acquisitions rather than rapid diversification.
- Safety technologies: life-critical sensing and monitoring systems for industrial and healthcare settings that reduce risk and save lives.
- Environmental solutions: sensors and controls to protect water quality, reduce emissions and improve resource efficiency.
- Healthcare products: diagnostic, monitoring and treatment-enabling devices that improve patient outcomes and workflow efficiency.
| Impact area | Examples of measurable indicators |
|---|---|
| Lives and safety | Installed safety-critical systems, incidents avoided, regulatory approvals obtained |
| Environmental protection | Units deployed for water/air monitoring, reductions in pollutant levels enabled by solutions |
| Healthcare outcomes | Device adoption rates, clinical validation studies, improvements in clinical throughput or patient recovery metrics |
- Steady financial performance and margin expansion have supported ongoing reinvestment in mission-aligned R&D and acquisitions.
- Shareholders typically value Halma's predictable cash conversion and disciplined capital allocation that underpin mission delivery.
- For deeper investor-oriented context see: Exploring Halma plc Investor Profile: Who's Buying and Why?
Halma plc (HLMA.L) - Mission Statement
Halma plc's mission is to develop and deploy technologies that make the world safer, healthier and cleaner. That mission drives product innovation across its specialist safety, health and environmental markets and underpins strategy, capital allocation and performance targets.- Mission focus: life-saving, safety-critical and environmentally protective solutions delivered at scale across industrial, medical, and infrastructure markets.
- Strategic approach: acquire, integrate and grow high-quality niche businesses that deliver differentiated technology and recurring revenue.
- Operational priorities: high margins, strong cash conversion and disciplined reinvestment into R&D and M&A consistent with the Sustainable Growth Model.
- Safety & health commitment: products and services designed to reduce harm and improve outcomes across healthcare settings, industrial sites and public environments.
- Compliance-first culture: global regulatory adherence and product validation frameworks to ensure the highest standards.
- Stakeholder value: aligning growth with social and environmental benefits for customers, employees and communities.
- Strategic alignment: Halma's Sustainable Growth Model ensures acquisitions and organic investment reinforce the vision.
- Customer focus - rapid product innovation, long-term service contracts and strong after-sales support.
- Integrity - robust compliance frameworks, supplier standards and clinical/regulatory governance.
- Collaboration - decentralised operating model that empowers local management and leverages group expertise.
- Continuous improvement - systematic reinvestment in R&D and disciplined M&A to scale proven technologies.
| Metric | Figure (most recent FY) |
|---|---|
| Revenue | ≈ £1.64 billion |
| Underlying operating profit | ≈ £320 million |
| Underlying EPS | ≈ 38 pence |
| Dividend per share | ≈ 11.2 pence |
| Employees | ≈ 8,000 |
| Approx. market capitalisation | ≈ £7.5 billion |
- Organic growth plus targeted bolt-on acquisitions to sustain mid-single-digit to high-single-digit revenue growth.
- Focus on high-margin, recurring revenue streams to preserve operating margin in the high-teens to low-twenties percentage range.
- Cash conversion and return on invested capital targets that prioritise shareholder returns and reinvestment into mission-critical capabilities.
- Life-saving technologies: Halma portfolio companies supply critical devices and detection systems used in hospitals and emergency response.
- Workplace safety: industrial sensors and automation solutions that reduce incidents and improve regulatory compliance for customers worldwide.
- Environmental protection: monitoring and mitigation products that help clients meet environmental standards and reduce pollution risks.
Halma plc (HLMA.L) Vision Statement
Halma plc's vision is to be the global leader in safety, health and environmental technologies by delivering reliable, innovative products and services that prevent hazards, save lives and protect assets - while generating sustainable shareholder value.- Integrity: Halma embeds ethical practice, transparent reporting and robust corporate governance across a decentralised corporate model. The Group's Code of Conduct and whistleblowing arrangements support consistent standards across 6,000+ employees worldwide.
- Innovation: R&D investment and targeted acquisitions drive product cycles that address emerging market needs in medical, infrastructure and environmental safety.
- Collaboration: Autonomous operating companies collaborate through shared platforms (commercial, technology and M&A) to scale proven solutions across geographies.
- Responsibility: Sustainability and ESG are operational priorities - reducing environmental impact, improving product lifecycle impacts and advancing workforce wellbeing.
- Excellence: Continuous improvement, disciplined capital allocation and high service standards underpin Halma's ability to sustain margins and customer trust.
| Metric | Value |
|---|---|
| Annual Group revenue | ≈ £1.8 billion |
| Operating margin (approx.) | ~20% |
| Employees | ~6,000 |
| Geographic reach | Sales in 100+ countries |
| Market capitalisation (approx.) | Several billion GBP (FTSE-listed) |
| Dividend policy | Progressive dividend with regular increases |
- R&D and acquisitions: Halma grows by combining organic innovation with bolt-on acquisitions that extend technical capability and market access, focusing capital on safety- and health-related niches with recurring revenues.
- Sustainable growth: Emphasis on products with long product lives, serviceable components and recurring aftermarket revenues helps protect margins and support responsible resource use.
- Operational governance: Decentralised operating companies are held to common performance and ESG metrics to ensure integrity, compliance and consistent customer outcomes.

Halma plc (HLMA.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.